Capecitabine plus oxaliplatin compared with 5-fluorouracil plus oxaliplatin in metastatic colorectal cancer: Meta-analysis of randomized controlled trials

By                

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 831-838

Spandidos Publications

Access to resources Recommend Favorite

Oxaliplatin, colorectal cancer and predictive factors

By Esteve Albert  

Clinical and Translational Oncology, Vol. 13, Iss. 6, 2011-06 ,pp. : 353-354

Springer Publishing Company

Access to resources Recommend Favorite

Carcinoembryonic Antigen (CEA)-Based Cancer Vaccines: Recent Patents and Antitumor Effects from Experimental Models to Clinical Trials

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Iss. 3, 2012-09 ,pp. : 265-296

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of advanced colorectal cancer with 5-fluorouracil and interferon- : An overview of clinical trials

By Raderer M.   Scheithauer W.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 1002-1008

Elsevier

Access to resources Recommend Favorite

A Phase I Study of Hyperthermic Isolated Hepatic Perfusion with Oxaliplatin in the Treatment of Unresectable Liver Metastases from Colorectal Cancer

By Zeh Herbert   Brown Charles   Holtzman Matthew   Egorin Merrill   Holleran Julianne   Potter Douglas   Bartlett David  

Annals of Surgical Oncology, Vol. 16, Iss. 2, 2009-02 ,pp. : 385-394

Springer Publishing Company

Access to resources Recommend Favorite